MRV
vs
S
S&P TSX Composite Index (Canada)
MRV
Over the past 12 months, MRV has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +28% growth.
Stocks Performance
MRV vs S&P TSX Composite Index (Canada)
Performance Gap
MRV vs S&P TSX Composite Index (Canada)
Performance By Year
MRV vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nuvo Pharmaceuticals Inc
Glance View
Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. The company is headquartered in Mississauga, Ontario and currently employs 100 full-time employees. The firm is engaged in offering diversified portfolio of commercial products. The company operates through three segments: Commercial Business, Production and Service Business and Licensing and Royalty Business. The Commercial Business segment is comprised of products commercialized by the Company in Canada. The company includes products, such as Blexten, Cambia, Suvexx and NeoVisc, as well as mature products. The Production and Service Business segment includes sale of products manufactured by the Company from its manufacturing facility in Varennes, Quebec or contracted by Miravo Ireland from its international headquarters in Dublin, Ireland, as well as service for testing, development and related quality assurance and quality control services provided by the Company. The Licensing and Royalty Business segment includes the revenue by the licensing of intellectual property and ongoing royalties from licensing agreements with partners.
